Dipropanoylmorphine

From WikiMD's Medical Encyclopedia

Revision as of 05:11, 16 February 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

A semi-synthetic opioid derived from morphine


Dipropanoylmorphine
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number 8002-20-2
PubChem
DrugBank
ChemSpider
KEGG


Dipropanoylmorphine is a semi-synthetic opioid derived from morphine. It is an ester of morphine, specifically the 3,6-dipropionate ester. This compound is part of a class of drugs known as opioid analgesics, which are used for their pain-relieving properties.

Chemical Structure and Properties

Chemical structure of Dipropanoylmorphine

Dipropanoylmorphine is chemically similar to morphine, with the addition of two propionyl groups at the 3 and 6 positions of the morphine molecule. This modification alters its pharmacokinetic properties, potentially affecting its potency, duration of action, and solubility compared to morphine.

Pharmacology

Dipropanoylmorphine acts on the opioid receptors in the central nervous system, primarily the mu-opioid receptor. This interaction leads to the inhibition of neurotransmitter release, resulting in analgesia, sedation, and euphoria. Like other opioids, it can also cause respiratory depression, constipation, and physical dependence.

Medical Use

While dipropanoylmorphine has been studied for its analgesic properties, it is not commonly used in clinical practice. The development of more effective and safer opioid analgesics has limited its use. However, it remains of interest in research settings for understanding the structure-activity relationships of opioid compounds.

Synthesis

The synthesis of dipropanoylmorphine involves the esterification of morphine with propionic anhydride. This chemical reaction results in the formation of the dipropionate ester, which is dipropanoylmorphine. The process requires careful control of reaction conditions to ensure the desired product is obtained.

Legal Status

Dipropanoylmorphine is classified as a controlled substance in many jurisdictions due to its potential for abuse and addiction. Its legal status is similar to that of other opioids, and it is subject to strict regulations regarding its manufacture, distribution, and use.

Related pages

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.